Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis

Creative Commons License

Demir C. F., Balgetir F., Ethemoglu O., Aksoy D., Aktas F., Koca S. S., ...More

ARCHIVES OF RHEUMATOLOGY, vol.36, no.2, pp.219-226, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.46497/archrheumatol.2021.8229
  • Journal Name: ARCHIVES OF RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.219-226
  • Keywords: Colchicine, resistant familial Mediterranean fever, familial Mediterranean fever, multiple sclerosis, ocrelizumab
  • Erciyes University Affiliated: Yes

Abstract

Objectives: This study aims to evaluate the effects of ocrelizumab (OCZ) on familial Mediterranean fever (FMF) attacks in multiple sclerosis (MS) patients with FMF (MS+FMF patients).